Moderna announced expansion of its manufacturing technology center in Massachusetts
On May 4, 2021, Moderna announced an expansion of the Moderna Technology Center (MTC) in Norwood, MA including…
HDT Bio, Gennova Biopharma announced volunteers dosed in phase I/II trials of COVID-19 RNA vaccine in India
On May 4, 2021, HDT Bio announced that its development partner in India, Gennova Biopharmaceuticals, had begun dosing…
Researchers wirelessly recorded human brain activity during normal life activities
On May 3, 2021, the National Institutes of Health announced that researchers wre able to wirelessly record the…
The 12th Ebola outbreak in the Democratic Republic of the Congo declared over
On May 3, 2021, the World Health Organization (WHO) announced the end of the 12th outbreak of Ebola…
COVID-19 | Life Science News | Vaccine | WHO
WHO welcomed Sweden’s announcement to share COVID-19 vaccine doses with COVAX
On May 3, 2021, the World Health Organization (WHO) welcomed the Government of Swedenﾒs announcement to share 1…
University of British Columbia researchers unveiled first molecular images of B.1.1.7 COVID-19 mutation
On May 3, 2021, University of British Columbia (UBC) researchers were the first in the world to publish…
Eiger announced Peginterferon Lambda added to multi-center phase 3 TOGETHER COVID-19 study in Brazil
On May 3, 2021, Eiger BioPharmaceuticals announced announced that Peginterferon Lambda (Lambda) will be added to the ongoing,…
Data from Vaxart oral COVID-19 vaccine phase I study suggested broad cross-reactivity against Coronaviruses
On May 3, 2021, Vaxart announced that new data obtained from its Phase I COVID-19 trial added to…
Precipio launched Rapid COVID-19 Antibody test on Amazon platform
On May 3, 2021, Precipio announced that it had successfully launched its COVID-19 rapid antibody test (20 minute)…
Moderna announced supply agreement with Gavi for up to 500 million doses of COVID-19 Vaccine Moderna for COVAX
On May 3, 2021, Moderna announced an agreement with Gavi, the Vaccine Alliance to supply up to 500…
Novavax initiated pediatric expansion for phase 3 clinical trial of COVID-19 vaccine
On May 3, 2021, Novavax announced that it had initiated a pediatric expansion of its Phase 3 clinical…
Gavi signed agreement with Moderna to secure doses on behalf of COVAX Facility
On May 3, 2021, Gavi, the Vaccine Alliance, that it had signed an advance purchase agreement with Moderna…
FDA approved treatment for chronic kidney disease
On Apr. 30, 2021, the FDA approved AstraZeneca’s Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney…
FDA revoked the EUA of the Battelle CCDS Critical Care Decontamination System
On Apr. 30, 2021, the FDA revoked the emergency use authorization (EUA) of the Battelle CCDS Critical Care…
Moderna announced Emergency Use listing granted by the WHO for its COVID-19 vaccine
On Apr. 30, 2021, Moderna announced that the World Health Organization (WHO) had issued Emergency Use Listing (EUL)…
Lonza and Moderna entered agreement to double drug substance production for COVID-19 vaccine in Visp
On Apr. 29, 2021, Lonza announced the expansion of its collaboration with Moderna to manufacture the drug substance…
COVID-19 | Life Science News | NIH | Vaccine
NIH announced investment of $29 million to address COVID-19 disparities
On Apr. 29, 2021, the National Institutes of Health announced it was funding $29 million in additional grants…
Babyﾒs first poop predicted risk of developing allergies
On Apr. 29, 2021, researchers at the University of British Columbia announced a study published in Cell Reports…
Large collaboration created cell atlas of COVID-19 pathology
On Apr. 29, 2021, scientists from several hospitals and research centers reported what happens in individual cells of…
Moderna announced an increased global supply for COVID-19 vaccine to up to 3 billion doses in 2022
On Apr. 29, 2021, Moderna announced it was making new funding commitments to increase supply at its owned…
Pfizer and BioNTech submitted request to expand conditional marketing authorization of COMIRNATY in EU to adolescents
On Apr. 29, 2021, Pfizer and BioNTech announced they had submitted a variation to the Conditional Marketing Authorization…
HHMI announced project to read genomes of all 70,000 vertebrate species
On Apr. 28, 2021, HHMI investigator Erich Jarvis and dozens of colleagues announced they had launched an ambitious…
XPhyto pursued market access in Israel for its COVID-19 PCR Rapid Test
On Apr. 28, 2021, XPhyto announce that it has delivered 2,000 of its rapid 25-minute PCR tests (ﾓCovid-ID…
VBI Vaccines announced publication of Challenge Study Data of its eVLP vaccine candidate against COVID-19
On Apr. 28, 2021, VBI Vaccines announced that preclinical data of VBIﾒs enveloped virus-like particle (eVLP) vaccine candidate,…
Innovation Pharma surpassed 50 percent enrollment in phase 2 clinical trial of Brilacidin for COVID-19
On Apr. 28, 2021, Innovation Pharma announced that enrollment had surpassed 50 percent of the total targeted number…
Scientists released error-free genomes of 25 animals with another 70,000 coming up
On Apr. 28, 2021, Rockefeller University researchers announced the launch the Vertebrate Genomes Project, an ambitious initiative launched…
Fully vaccinated adults 65 and older are 94% less likely to be hospitalized with COVID-19
On Apr. 28, 2021, the Centers for Disease Control and Prevention (CDC) announced that both mRNA COVID-19 vaccines…
Merck announced licensing agreements with Indian manufacturers to expand access to molnupiravir for treatment of COVID-19
On Apr. 27, 2021, Merck announced the company had entered into non-exclusive voluntary licensing agreements for molnupiravir with…
AIM ImmunoTech announced positive safety data in second cohort of phase 1 study Investigating intranasal administration of Ampligen as treatment for COVID-19
On Apr. 27, 2021, AIM ImmunoTech announced that it had completed dosing of Cohort 2 in a Phase…
CerTest Biotec, BD announced addition of saliva to CE Marked VIASURE SARS-CoV-2 Real Time PCR Detection Kit for BD MAX
On Apr. 27, 2021, CerTest Biotec, along with BD announced the VIASURE SARS-CoV-2 (N1 + N2) Real Time…